Shares of MAIA Biotechnology, a company with a market capitalization of $65 million that develops therapies for cancer, surged more than 8% on Tuesday, October 29, following the announcement of a private placement, which included certain insiders and is expected to raise $2.44 million. Details On Tuesday, MAIA stock gained…